| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | Jul 23, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 20.0 | -129,206 | -80.49% | ✗ | $988.5K |
| Jul 17, 2024 | Jul 19, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 20.0 | -41,783 | -20.65% | ✗ | $289.5K |
| Jul 16, 2024 | Jul 17, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 20.0 | -50,000 | -19.82% | ✗ | $356.5K |
| Jul 12, 2024 | Jul 16, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 20.0 | -92,377 | -26.80% | ✗ | $650.6K |
| Jul 9, 2024 | Jul 11, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 20.0 | -105,931 | -23.51% | ✗ | $736.5K |
| Jul 5, 2024 | Jul 9, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 22.5 | -12,342 | -2.67% | ✗ | $87.1K |
| Jul 1, 2024 | Jul 3, 2024 | Climb Bio, Inc. | EVP, R&D AND CSO | Sell | 20.0 | -50,000 | -9.75% | ✗ | $338K |